Marken Inaugurates New Branch in India
Marken continues their expansion of services in India, by augmenting their existing Mumbai facility with four additional branches to support the growing demand in clinical trial logistics within India. The expansion in New Delhi, Hydrabad, Pune and Bangalore will support the growing need for temperature controlled logistics of sensitive drugs and cold chain specimens. As part of their expansion in India, Marken recently ran a special client Awareness workshop on the air transport of infectious substances.
Marken is implementing their stated plan to build the most advanced, fit for purpose clinical Supply chain network to serve the pharmaceutical community. The new India offices build on Marken’s current clinical trial support services and enable the company to grow from its current industry-leading life sciences logistics platform. Marken is expanding their reach throughout India to support their clients rapidly increasing demand for supply chain management services of Active Pharmaceutical Ingredients (API), Investigational Medical Products (IMPs) and Clinical Trial Specimens.
“The expansion of our operations in India enables Marken to better support our clients’ need for regional expertise and temperature controlled supply chain services.” said Wes Wheeler, Marken’s Chief Executive Officer. “We have seen steady growth and demand of our specimen logistics, drug distribution and API supply chain services in India.”
Marken is currently developing a new purpose-built GMP compliant depot in Bangalore due to be complete by the end of 2012. The Bangalore Depot will join Marken’s already operational Argentina, Mexico and Singapore depots offering the full range of temperature controlled storage capabilities including: controlled ambient, refrigerated and frozen as Pharmaceuticals and Medical devices. Each of Marken’s depots provides drug and equipment distribution solutions including: Pick & Pack, relabeling services, reverse logistics, reconciliation and certified destruction. Additionally, the network manages specimen kit distribution, interim specimen storage and management.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
